VKVineetha K K

Vineetha K K

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Vineetha K K has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Development and validation of uterine fibroid quality of life and health-related lifestyle (UF-QLHRL) questionnaire in an Indian population

    by Vineetha K K, Rajeshwari G. Bhat, Archana P. R, Preetha Ramachandra, Vani Lakshmi R, Bhamini Krishna Rao


  • GC–MS quantification of fecal short‐chain fatty acids and spectrophotometric detection of indole: Do rectal swabs produce comparable results as stool samples? ‐ A pilot study

    by Vineetha K K, Archana P R, Bhamini Krishna Rao, Mamatha Ballal, Babi Dutta, Vani Lakshmi R, Rajeshwari G. Bhat

    Rationale: The exploration of the gut microbiome and related metabolites holds an exciting future in health science. The challenges associated with fecal sample testing are proper sample collection, sterile transportation, optimal transport conditions, and processing as all these factors could potentially change the microbiome composition, further exacerbated by the patient's customary discomfort regarding feces samples. The study aimed to compare the usage of rectal swabs and stool samples for short‐chain fatty acid estimation using gas chromatography–mass spectrometry (GC–MS) and indole estimation using spectrophotometry. Method: From May 2022 to June 2022, three women were recruited from the Department of Obstetrics and Gynecology (OBG) in a secondary care hospital in coastal Karnataka. During their clinical visit, a rectal swab was collected, and the stool sample was transported to the hospital from the patient's home in sterile containers provided. After the extraction, short‐chain fatty acids (acetate, propionate, and butyrate) were quantified using GC–MS. The fecal indole concentration was determined using a hydroxylamine‐based assay. Results: The GC–MS analysis failed to detect the concentrations of short‐chain fatty acids in rectal swab samples. Indole concentrations in stool and swab samples were significantly different. Conclusion: The study's findings do not support the use of rectal swabs to analyze gut metabolites.


  • Open Access

    The Gut Microbiota: a Novel Player in the Pathogenesis of Uterine Fibroids

    by Vineetha K K, Rajeshwari G Bhat, Bhamini Krishna Rao, Archana P R

    Uterine fibroid is a common gynecological disorder that affects women of reproductive age and has emerged as a major public health concern. The symptoms have a negative influence on both their physical health and quality of life. The cost of treatment has a significant impact on the disease’s burden. Even though its origin is uncertain, estrogen is thought to be a key player in fibroid pathophysiology. Many theories, including those based on genetic and environmental factors, explain what causes hyper-estrogenic condition in fibroid patients. One such possibility that is currently being explored is the hypothesis that an altered gut microbiome can contribute to the development of diseases characterized by estrogen dominance. Gut dysbiosis is often a “hot area” in the health sciences. According to a recent study, uterine fibroid patients have altered gut microbiome. A variety of risk factors influence both fibroid development and gut homeostasis. Diet, lifestyle, physical activity, and environmental contaminants have an impact on estrogen and the gut flora. A better understanding of uterine fibroids’ pathophysiology is required to develop effective preventative and treatment options. A few ways by which the gut microbiota contributes to UF include estrogen, impaired immune function, inflammation, and altered gut metabolites. Therefore, in the future, while treating fibroid patients, various strategies to deal with changes in the gut flora may be advantageous. For developing suggestions for clinical diagnosis and therapy, we reviewed the literature on the relationship between uterine fibroids and the gut microbiota.